193 related articles for article (PubMed ID: 9211755)
21. Technetium 99m tetrofosmin parathyroid imaging. Results with double-phase study and SPECT in primary and secondary hyperparathyroidism.
Gallowitsch HJ; Mikosch P; Kresnik E; Gomez I; Lind P
Invest Radiol; 1997 Aug; 32(8):459-65. PubMed ID: 9258734
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of thyroid nodules with technetium-99m MIBI and technetium-99m pertechnetate.
Sathekge MM; Mageza RB; Muthuphei MN; Modiba MC; Clauss RC
Head Neck; 2001 Apr; 23(4):305-10. PubMed ID: 11400232
[TBL] [Abstract][Full Text] [Related]
23. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
[TBL] [Abstract][Full Text] [Related]
24. Thallium-201, technetium-99m-tetrofosmin and iodine-131 in detecting differentiated thyroid carcinoma metastases.
Unal S; Menda Y; Adalet I; Boztepe H; Ozbey N; Alagöl F; Cantez S
J Nucl Med; 1998 Nov; 39(11):1897-902. PubMed ID: 9829579
[TBL] [Abstract][Full Text] [Related]
25. Scintigraphic and ultrasonographic appearance in different tumor stages of thyroid carcinoma.
Kresnik E; Gallowitsch HJ; Mikosch P; Unterweger O; Gomez I; Lind P
Acta Med Austriaca; 2000; 27(1):32-5. PubMed ID: 10812461
[TBL] [Abstract][Full Text] [Related]
26. Comparing dual phase Tl-201 thyroid scan and fine-needle aspiration cytology to detect follicular carcinoma.
Leung HC; Chang CT; Wu HS; Wang TY; Sun SS; Kao CH
Endocr Res; 2003 Aug; 29(3):291-7. PubMed ID: 14535630
[TBL] [Abstract][Full Text] [Related]
27. Papillary thyroid carcinoma associated with parathyroid adenoma detected by pertechnetate-MIBI subtraction scintigraphy.
Rubello D; Toniato A; Pelizzo MR; Casara D
Clin Nucl Med; 2000 Nov; 25(11):898-900. PubMed ID: 11079587
[TBL] [Abstract][Full Text] [Related]
28. The usefulness of Tc-99m tetrofosmin scintigraphy in the diagnosis and localization of hyperfunctioning parathyroid glands.
Vallejos V; Martin-Comin J; Gonzalez MT; Rafecas R; Muñoz A; Fernãndez A; Mora J; Ramos M
Clin Nucl Med; 1999 Dec; 24(12):959-64. PubMed ID: 10595477
[TBL] [Abstract][Full Text] [Related]
29. A comparison of radionuclide thyroid angiography, (99m)Tc-MIBI scintigraphy and power Doppler ultrasonography in the differential diagnosis of solitary cold thyroid nodules.
Demirel K; Kapucu O; Yücel C; Ozdemir H; Ayvaz G; Taneri F
Eur J Nucl Med Mol Imaging; 2003 May; 30(5):642-50. PubMed ID: 12612810
[TBL] [Abstract][Full Text] [Related]
30. (99m)Tc-Methoxy-Isobutyl-Isonitrile Scintigraphy Is a Useful Tool for Assessing the Risk of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Cytology.
Campennì A; Giovanella L; Siracusa M; Alibrandi A; Pignata SA; Giovinazzo S; Trimarchi F; Ruggeri RM; Baldari S
Thyroid; 2016 Aug; 26(8):1101-9. PubMed ID: 27266385
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of thyroid nodules for malignancy using 99Tcm-sestamibi.
Sundram FX; Mack P
Nucl Med Commun; 1995 Aug; 16(8):687-93. PubMed ID: 7491182
[TBL] [Abstract][Full Text] [Related]
32. [The use of imaging modalities in patient with thyroid nodule: ultrasonography and radionuclide scintigraphy with new tracers].
Hod N; Strauss S; Horne T
Harefuah; 2001 May; 140(5):421-4. PubMed ID: 11419067
[No Abstract] [Full Text] [Related]
33. Investigation of thyroid nodules using technetium-99m sestamibi.
Sundram FX; Mack PO
Ann Acad Med Singap; 1993 Jul; 22(4):560-2. PubMed ID: 8257058
[No Abstract] [Full Text] [Related]
34. Quantitative comparison of technetium-99m tetrofosmin and thallium-201 images of the thyroid and abnormal parathyroid glands.
Giordano A; Marozzi P; Meduri G; Ficola U; Calcagni ML; Vaccaro A; Rubini G; Attard M; Li Puma M; Ricci R; Corsello S
Eur J Nucl Med; 1999 Aug; 26(8):907-11. PubMed ID: 10436206
[TBL] [Abstract][Full Text] [Related]
35. Technetium-99m tetrofosmin imaging in patients with subacute thyroiditis.
Hiromatsu Y; Ishibashi M; Miyake I; Nonaka K
Eur J Nucl Med; 1998 Oct; 25(10):1448-52. PubMed ID: 9818287
[TBL] [Abstract][Full Text] [Related]
36. Differentiation of benign from malignant nodules by accumulation of Tc-99m pertechnetate using TI-201 delayed scans.
Okumura Y; Takeda Y; Sato S; Shimizu M; Komatsu M; Honda O; Nakagawa T; Niiya H; Hiraki Y
Clin Nucl Med; 1998 Aug; 23(8):514-6. PubMed ID: 9712383
[TBL] [Abstract][Full Text] [Related]
37. Association of hyperfunctioning thyroid adenoma with thyroid cancer presenting as "trapping only" nodule at 99mTcO4- scintigraphy.
dell'Erba L; Gerundini P; Caputo M; Bagnasco M
J Endocrinol Invest; 2003 Nov; 26(11):1124-7. PubMed ID: 15008253
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of thyroid nodules--combined use of (99m)Tc-methylisobutylnitrile scintigraphy and aspiration cytology to assess risk of malignancy and stratify patients for surgical or nonsurgical therapy--a retrospective cohort study.
Leidig-Bruckner G; Cichorowski G; Sattler P; Bruckner T; Sattler B
Clin Endocrinol (Oxf); 2012 May; 76(5):749-58. PubMed ID: 22078001
[TBL] [Abstract][Full Text] [Related]
39. The role of F-18FDG PET in thyroid cancer.
Lind P; Kumnig G; Matschnig S; Heinisch M; Gallowitsch HJ; Mikosch P; Kresnik E; Gomez I; Unterweger O
Acta Med Austriaca; 2000; 27(2):38-41. PubMed ID: 10812462
[TBL] [Abstract][Full Text] [Related]
40. 99mTc-tetrofosmin or 99mTc-sestamibi for double-phase parathyroid scintigraphy?
Fröberg AC; Valkema R; Bonjer HJ; Krenning EP
Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):193-6. PubMed ID: 12552335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
